Novavax shares are trading higher after the CDC said trial participants in the company's PREVENT-19 Phase 3 clinical trial meet the criteria to be considered fully vaccinated two weeks after they have...
Source LinkNovavax shares are trading higher after the CDC said trial participants in the company's PREVENT-19 Phase 3 clinical trial meet the criteria to be considered fully vaccinated two weeks after they have...
Source Link
Comments